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We report a 64 year-old woman with longstanding
hereditary angioedema who previously required a
tracheotomy.
In September 2005, while receiving prophylactic Dana-
zol she noticed a left sided swelling involving her throat
and uvula that was of moderate intensity by 1110h. She
came to hospital and received icatibant 30 mg sc at
1330h when the swelling was 1 cm in size. One hour
later the swelling was 4 mm in size. After 2 hours the
swelling was gone and did not recur.
Because of increased frequency of angioedema, after
December 2008 she started taking C1 esterase inhibitor
2000 PU once weekly, and Danazol 400 mg daily plus
additional C1 inhibitor infusions when symptoms were
uncontrolled. She received icatibant in August 2009 for
throat swelling. Her symptoms subsided and admission
wasn’t required. In November 2009, she was admitted
for a bowel obstruction due to angioedema. She received
as i n g l ed o s eo fi c a t i b a n t ,b u td i dn o tn o t ea n yb e n e f i t .
Treatment with icatibant was not repeated. With con-
servative treatment and additional C1 esterase inhibitor,
her bowel obstruction gradually resolved over 3 days.
Her C4 was undetectable (<0.02 g/L) and C1 esterase
inhibitor was within the normal range (0.22 g/L normal
0.21-0.39 g/L).
We present a patient with hereditary angioedema
whose throat angioedema responded to icatibant but a
single dose of icatibant did not have significant effect on
bowel angioedema. Physicians should consider icatibant
for breakthrough attacks not prevented by prophylactic
therapy.
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